Recent Press Releases

goBalto Raises $12 million from Mitsui Global Investment and Dolby Family Ventures

SAN FRANCISCO -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that it secured $12 million in funding from Mitsui Global Investment and Dolby...

Covance Launches New Solution to Bridge Preclinical to Clinical Development

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced the introduction of Covance Early Phase Development Solutions, a...

PPD Expands GMP Laboratory in Athlone, Ireland

WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) has expanded its good manufacturing practices (GMP) operations in Athlone, Ireland, by adding a new, state-of-the-art laboratory for...

INC Enhances Clinical Delivery Focus With Executive Leadership Promotions

COO Alistair Macdonald Promoted to President and Chief Operating Officer; CNS President and General Manager Michael Gibertini, PhD, Appointed President, Clinical Development to Lead Company's...

Date Set for Arbitration Trial Between CEL-SCI and Clinical Research Organization inVentiv

VIENNA, Va.--CEL-SCI Corporation (NYSE MKT:CVM) today announced that the trial in its ongoing arbitration against inVentiv Clinical, LLC (f/k/a PharmaNet, LLC and PharmaNet GmbH (f/k/a PharmaNet...

Ergomed 2014 Business Update

Expected revenue growth of 14% 40% increase in new contracts won in H2 2014 Guildford, UK – 20 January 2015: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company,...

AMRI RECEIVES NIH CONTRACT AWARD FOR THE FORMULATION DEVELOPMENT AND MANUFACTURE OF PRE-CLINICAL AND CLINICAL DRUG PRODUCT

- 10-YEAR FEDERAL CONTRACT AWARD VALUED AT UP TO $37 MILLION - ALBANY, N.Y., Jan. 19, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it received a 10-year federal contract award from...

Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme

* Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure across chemistry & biology * Efforts will combine the use of C4XD's proprietary NMR...

Catalent & Sanofi To Collaborate On SMARTag™ Antibody-Drug Conjugate Technology With Sanofi's Proprietary Antibodies

Somerset, N.J., USA – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has...

Clinipace Worldwide Closes on $50 Million M&A War Chest

Clinipace Worldwide Closes on $50 Million M&A War Chest Funding to Fuel Additional Expansion After 40% Year-over-Year Growth in 2014 MORRISVILLE, N.C. (Business Wire) JANUARY 15, 2015 –...

Jamie Macdonald of INC Research Elected 2015 ACRO Chairman

WASHINGTON--The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jamie Macdonald, CEO of INC Research (NASDAQ: INCR), as its 2015...

Novella Clinical and the Cardiovascular Research Foundation Collaborate to Provide Comprehensive Clinical Trial Expertise

RESEARCH TRIANGLE PARK, N.C.--Novella Clinical, a Quintiles company (Novella), and the Cardiovascular Research Foundation (CRF) today announced a preferred provider collaboration that will offer a...

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration HAMBURG, Germany, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Evotec AG (EVT.F) (TecDAX) (ISIN:DE0005664809) and...

X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases

--X-Chem to Identify Small Molecule Leads Using its Proprietary Discovery Engine Fueled by a DNA-Encoded Library Exceeding 100 Billion Compounds-- WALTHAM, Mass.--X-Chem, Inc....

AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses

ALBANY, N.Y., Jan. 9, 2015 -- AMRI (NASDAQ: AMRI) today announced that it has acquired the outstanding equity interests of Aptuit's Glasgow, UK business and has entered into a definitive...

Evotec and Ohio State to collaborate on novel cancer therapy

*Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure *Efforts will explore the use of a novel approach, discovered at Ohio State, for targeting mutant...

WuXi Launches Mobile App to Enable Chemistry-on-the-Go

SHANGHAI, Jan. 5, 2015 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical...

PPD and SNBL Announce Japanese Clinical Development Joint Venture and Additional Collaborations

WILMINGTON, N.C. & TOKYO--Pharmaceutical Product Development, LLC (PPD) and Shin Nippon Biomedical Laboratories Ltd. (SNBL) (TSE:2395) today announced an agreement to form a joint venture that...

WIL Research Partners with Instem for Global Harmonization Project

CONSHOHOCKEN, Pa. -- Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WIL Research has placed an expanded order for the deployment of...

X-Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

--- Second license granted to Bayer within a year--- WALTHAM, Mass.--X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the...